Ms Joanne Ottomanelli, PT | |
340 Pine Rd, Briarcliff, NY 10510-2203 | |
(914) 944-3236 | |
Not Available |
Full Name | Ms Joanne Ottomanelli |
---|---|
Gender | Female |
Speciality | Physical Therapist |
Location | 340 Pine Rd, Briarcliff, New York |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255626586 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | 005923-1 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Joanne Ottomanelli, PT 340 Pine Rd, Briarcliff, NY 10510 Ph: (914) 944-3236 | Ms Joanne Ottomanelli, PT 340 Pine Rd, Briarcliff, NY 10510-2203 Ph: (914) 944-3236 |
News Archive
A Michigan State University researcher is analyzing the immune system's own ability to protect the body against lung cancer.The results of the work by Alison Bauer, an assistant professor of pathobiology and diagnostic investigation in the College of Veterinary Medicine, are expected to provide new approaches to prevent, identify and treat lung cancer.
Matthew D. McHugh, PhD, CRNP, MPH, JD, an assistant professor at the University of Pennsylvania School of Nursing, has won a competitive grant from the Robert Wood Johnson Foundation (RWJF) to study the relationships among where people live, where they receive hospital care, and the outcomes of that care.
Canadian teenagers are among the largest consumers of cannabis worldwide. The damaging effects of this illicit drug on young brains are worse than originally thought, according to new research by Dr. Gabriella Gobbi, a psychiatric researcher from the Research Institute of the McGill University Health Centre. The new study, published in Neurobiology of Disease, suggests that daily consumption of cannabis in teens can cause depression and anxiety, and have an irreversible long-term effect on the brain.
InNexus Biotechnology Inc., a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced that it has developed IXS312(VEGF), an antibody fragment with activity against the growth factor VEGF for planned use in ocular treatments.
In March 2002, Brown University researchers published an astounding piece of science. Three rhesus monkeys, they reported, could control a computer cursor without their hands. They used their minds instead.
› Verified 7 days ago
Iron Health Physical Therapist Medicare: Medicare Enrolled Practice Location: 541 N State Rd, Briarcliff, NY 10510 Phone: 914-222-0479 |